A Canadian Discovery Moves from the Lab to Clinical Trials

A new potential treatment for diabetic macular edema and agerelated macular degeneration has been discovered by Canadian scientist Dr. Przemyslaw (Mike) Sapieha (Université de Montréal).

The primary treatment for these diseases is anti-VEGF injections which stop the growth of blood vessels. One of the problems with this type of treatment is that all blood vessel growth is stopped; both abnormal blood vessels and sometimes healthy blood vessels which are needed to keep the eye healthy and protect vision.

In a new study published in Cell Metabolism, Dr. Sapieha’s team identified a way to distinguish between healthy and diseased blood vessels. They identified a molecule, BCL-xL, that is higher in abnormal blood vessels compared to healthy vessels. Dr. Sapieha then teamed up UNITY Biotechnology, who have developed drugs that block BCL-xL function. One of these drugs slowed the growth of abnormal vessels in a mouse model of retinal degeneration while allowing healthy blood vessels to survive.

This class of drugs is now being tested in a Phase I human clinical trial to determine safety in individuals with diabetic macular edema or wet age-related macular degeneration.

Featured Posts

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Learn More

Pender: A Classic Styling by AYA

Pender draws upon vintage references and combines contemporary cool.

Read more

opti 2023 Set to Start Two Weeks Earlier

opti 2023 is to be held from January 13 to 15. The ophthalmic optics sector will be able to start the new year and lay the foundations for successful business deals at the Fairground Munich. 

Read more

Transitions Announces New “From Screens to Sun. Face the Light.” Campaign

From ultraviolet to harmful blue light, Transitions lenses help to protect the eyes across light situations.

Read more

Cycle for Sight Returns In-Person to GTA

Goal to raise over $500,000 for critical vision research in Canada

Read more

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Learn More

Pender: A Classic Styling by AYA

Pender draws upon vintage references and combines contemporary cool.

Read More

opti 2023 Set to Start Two Weeks Earlier

opti 2023 is to be held from January 13 to 15. The ophthalmic optics sector will be able to start the new year and lay the foundations for successful business deals at the Fairground Munich. 

Read More

Transitions Announces New “From Screens to Sun. Face the Light.” Campaign

From ultraviolet to harmful blue light, Transitions lenses help to protect the eyes across light situations.

Read More

Cycle for Sight Returns In-Person to GTA

Goal to raise over $500,000 for critical vision research in Canada

Read More

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Learn More

Pender: A Classic Styling by AYA

Pender draws upon vintage references and combines contemporary cool.

Read more

opti 2023 Set to Start Two Weeks Earlier

opti 2023 is to be held from January 13 to 15. The ophthalmic optics sector will be able to start the new year and lay the foundations for successful business deals at the Fairground Munich. 

Read more

Transitions Announces New “From Screens to Sun. Face the Light.” Campaign

From ultraviolet to harmful blue light, Transitions lenses help to protect the eyes across light situations.

Read more

Cycle for Sight Returns In-Person to GTA

Goal to raise over $500,000 for critical vision research in Canada

Read more

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Learn More

Pender: A Classic Styling by AYA

Pender draws upon vintage references and combines contemporary cool.

Read more

opti 2023 Set to Start Two Weeks Earlier

opti 2023 is to be held from January 13 to 15. The ophthalmic optics sector will be able to start the new year and lay the foundations for successful business deals at the Fairground Munich. 

Read more

Transitions Announces New “From Screens to Sun. Face the Light.” Campaign

From ultraviolet to harmful blue light, Transitions lenses help to protect the eyes across light situations.

Read more

Cycle for Sight Returns In-Person to GTA

Goal to raise over $500,000 for critical vision research in Canada

Read more